{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:52:20Z","timestamp":1762332740377,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017239","name":"BeiGene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vhri.2025.101162","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:20:30Z","timestamp":1757100030000},"page":"101162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epidemiology, Real-World Treatment, and Economic Burden of Waldenstr\u00f6m Macroglobulinemia: A Comprehensive Analysis Based on Anonymized Claims Data Between 2010 and 2022"],"prefix":"10.1016","volume":"50","author":[{"given":"Christian","family":"Buske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasim","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keri","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vhri.2025.101162_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminhematol.2023.03.009","article-title":"Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom\u2019s macroglobulinemia on diagnostic and response criteria","volume":"60","author":"Treon","year":"2023","journal-title":"Semin Hematol"},{"issue":"11","key":"10.1016\/j.vhri.2025.101162_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vhri.2025.101162_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.seminhematol.2023.03.008","article-title":"The epidemiology of Waldenstr\u00f6m macroglobulinemia","volume":"60","author":"McMaster","year":"2023","journal-title":"Semin Hematol"},{"issue":"15","key":"10.1016\/j.vhri.2025.101162_bib4","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/cncr.26627","article-title":"Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study","volume":"118","author":"Wang","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.vhri.2025.101162_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.mayocp.2018.02.011","article-title":"Fifty-year incidence of Waldenstr\u00f6m macroglobulinemia in Olmsted County, Minnesota, from 1961 through 2010: a population-based study with complete case capture and hematopathologic review","volume":"93","author":"Kyle","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.vhri.2025.101162_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.leukres.2007.02.002","article-title":"The incidence and survival of Waldenstr\u00f6m\u2019s macroglobulinaemia in South East England","volume":"32","author":"Phekoo","year":"2008","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.vhri.2025.101162_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/0284186X.2015.1096019","article-title":"Familial Waldenstrom\u2019s macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies\u2013a population-based study from northern Sweden","volume":"55","author":"Brandefors","year":"2015","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.vhri.2025.101162_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/bjh.13264","article-title":"Overall survival and competing risks of death in patients with Waldenstr\u00f6m macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database","volume":"169","author":"Castillo","year":"2015","journal-title":"Br J Haematol"},{"issue":"25","key":"10.1016\/j.vhri.2025.101162_bib9","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood-2014-05-574871","article-title":"Survival trends in Waldenstr\u00f6m macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database","volume":"123","author":"Castillo","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vhri.2025.101162_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajh.23351","article-title":"Patterns of survival in lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005","volume":"88","author":"Kristinsson","year":"2013","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.vhri.2025.101162_bib11","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.3324\/haematol.2016.157768","article-title":"Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century","volume":"102","author":"Weberpals","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.vhri.2025.101162_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ajh.22027","article-title":"No significant improvement in the outcome of patients with Waldenstr\u00f6m\u2019s macroglobulinemia treated over the last 25 years","volume":"86","author":"Kastritis","year":"2011","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.vhri.2025.101162_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/pds.1721","article-title":"Review on use of German health insurance medication claims data for epidemiological research","volume":"18","author":"Hoffmann","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.vhri.2025.101162_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healthpol.2016.01.007","article-title":"Status and perspectives of claims data analyses in Germany-a systematic review","volume":"120","author":"Kreis","year":"2016","journal-title":"Health Policy"},{"author":"Fricke","key":"10.1016\/j.vhri.2025.101162_bib18"},{"issue":"7","key":"10.1016\/j.vhri.2025.101162_bib19","doi-asserted-by":"crossref","first-page":"A722","DOI":"10.1016\/j.jval.2015.09.2741","article-title":"Incidence and prevalence estimations based on claims data \u2013 new methodological considerations","volume":"18","author":"Prosser","year":"2015","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101162_bib21","doi-asserted-by":"crossref","first-page":"c379","DOI":"10.1159\/000321525","article-title":"Prediction of mortality in patients undergoing maintenance hemodialysis by Charlson Comorbidity Index using ICD-10 database","volume":"117","author":"Chae","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"10.1016\/j.vhri.2025.101162_bib22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12885-020-06738-z","article-title":"Real-world treatment and survival of patients with advanced non-small cell lung cancer: a German retrospective data analysis","volume":"20","author":"Hardtstock","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.vhri.2025.101162_bib23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/1536867X1501500305","article-title":"Estimation of mean health care costs and incremental cost-effectiveness ratios with possibly censored data","volume":"15","author":"Chen","year":"2015","journal-title":"Stata J"},{"issue":"1","key":"10.1016\/j.vhri.2025.101162_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07120-9","article-title":"Incidence, prevalence, mortality, and causes of death in Waldenstr\u00f6m macroglobulinemia: a nationwide, population-based cohort study","volume":"20","author":"Jeong","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.vhri.2025.101162_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.28343","article-title":"Incidence of lymphoplasmacytic lymphoma\/Waldenstr\u00f6m\u2019s macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003","volume":"134","author":"Iwanaga","year":"2014","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.vhri.2025.101162_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2015.09.2401","article-title":"Sickness funds data analyses on prevalence & incidence and treatment of Waldenstrom\u2019s macroglobulinemia (Wm) in Germany","volume":"18","author":"Leisten","year":"2015","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.vhri.2025.101162_bib27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3","article-title":"Waldenstr\u00f6m\u2019s macroglobulinemia: incidence patterns in the United States, 1988-1994","volume":"82","author":"Groves","year":"1998","journal-title":"Cancer"},{"issue":"5-6","key":"10.1016\/j.vhri.2025.101162_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000360992","article-title":"Outcome disparities among ethnic subgroups of Waldenstr\u00f6m\u2019s macroglobulinemia: a population-based study","volume":"86","author":"Ailawadhi","year":"2014","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.vhri.2025.101162_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1634\/theoncologist.2016-0126","article-title":"Evolution of management and outcomes in Waldenstr\u00f6m macroglobulinemia: a population-based analysis","volume":"21","author":"Olszewski","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.vhri.2025.101162_bib30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hon.2740","article-title":"Rare lymphomas in routine practice\u2014treatment and outcome in Waldenstr\u00f6m\u2019s macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms","volume":"38","author":"Knauf","year":"2020","journal-title":"Hematol Oncol"},{"issue":"7","key":"10.1016\/j.vhri.2025.101162_bib31","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/cancers13071708","article-title":"Treatment patterns and outcomes in a nationwide cohort of older and younger veterans with Waldenstr\u00f6m macroglobulinemia, 2006-2019","volume":"13","author":"Chien","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.vhri.2025.101162_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10198-020-01247-z","article-title":"Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are na\u00efve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events","volume":"22","author":"Hardtstock","year":"2021","journal-title":"Eur J Health Econ"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:47:56Z","timestamp":1762332476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S2212109925000871"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101162","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, Real-World Treatment, and Economic Burden of Waldenstr\u00f6m Macroglobulinemia: A Comprehensive Analysis Based on Anonymized Claims Data Between 2010 and 2022","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101162"}}